Apolipoprotein B deficiency
Apolipoprotein B deficiency is an autosomal dominant disorder resulting from a missense mutation which reduces the affinity of apoB-100 for the low-density lipoprotein receptor (LDL Receptor). This causes impairments in LDL catabolism, resulting in increased levels of low-density lipoprotein in the blood. The clinical manifestations are similar to diseases produced by mutations of the LDL receptor, such as familial hypercholesterolemia. Treatment may include, niacin or statin or ezetimibe.[1]: 534
| Apolipoprotein B deficiency | |
|---|---|
| Other names | Familial defective apolipoprotein B-100 |
| Specialty | Medical genetics |
It is also known as "normotriglyceridemic hypobetalipoproteinemia".[2]
See also
References
- Braunwald, Eugene; Hauser, Stephen L.; et al. (2001). Harrison's Principles of Internal Medicine. McGraw-hill. pp. 2246–2247. ISBN 978-0-07-007272-5.
- Homer VM, George PM, du Toit S, Davidson JS, Wilson CJ (July 2005). "Mental retardation and ataxia due to normotriglyceridemic hypobetalipoproteinemia". Ann. Neurol. 58 (1): 160–3. doi:10.1002/ana.20531. PMID 15984016. S2CID 6981284.
External links
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.